Life Insurance Corporation Of India / Q1-FY26

LICI Q1 FY26 earnings call.

A source-linked concall view: reported numbers, management language, guidance, commitments and risks that should carry forward.

Research layer active

ConCallIQ research layer

Signal, with the source still visible.

Use the controls below to narrow the view, then follow the evidence into the next layer of context.

Watch2025-08-09Back to LICI

Revenue

₹2,24,671 Cr

verified against source

Revenue YoY

4.77%

reported change

EBITDA

Pending

latest reported figure

Source

screener in

record provenance

Actual signal trajectory

Where this quarter sits.

source records only
Revenue (₹ Cr)PositiveWatchNegative
4 actual records
Actual quarterly Revenue (₹ Cr) trajectoryReported values plotted by quarter. Hover or focus a point for its quarter, value, and source sentiment.Q1 FY26: 2,24,671 · Watch source sentiment · 2025-08-09Q1 FY26Q2 FY26: 2,41,524 · Positive source sentiment · 2025-10-24Q2 FY26Q3 FY26: 2,35,954 · Watch source sentimentQ3 FY26Q1 FY27: 2,39,866 · Positive source sentimentQ1 FY272,41,5242,24,671
Values are taken from the available verified source records; sentiment color is a separate source-read indicator.

Quarter read

What the record says.

LIC reported steady Q1 FY26 results with total premium income of 1,19,200 crore (+4.77% YoY) and PAT of 10,986 crore (+5.02% YoY). The standout performer was VNB growth of 20.75% to 1,944 crore, with VNB margin expanding 150bps to 15.4%—driven by favorable product mix shift toward non-par products (now 30.34% of individual APE vs 23.94% YoY) and expense optimization (expense ratio down 140bps to 10.47%). Solvency strengthened to 2.17. However, policy count declined 14.75% to 30.79 lakh as average ticket size rose 23%, reflecting the strategic shift post surrender value regulation changes. Bank assurance and alternate channels posted exceptional 98.23% growth to 861.92 crore, now comprising 6.89% of individual NBP. Agent count grew 4.31% to 14.86 lakh. Management declined to provide specific FY26 growth guidance but expressed confidence in sustaining margin improvement trajectory through continued non-par mix expansion. Key risks include competitive pressure on market share (63.51% vs 64.02% YoY), persistency deterioration at 13th month (75.63% vs 78.23%), and potential regulatory shifts under RBC regime.

Colored figures show movement against the previous available record.

Guidance to track

  • Management indicated that as non-par proportion increases, corresponding margin improvement should follow. Non-par products have higher margins than par products, and ULIP growth contributes volume though at lower margins.
  • Group business accounts for approximately 30% of overall VNB despite lower margin profile. Focus is on shifting mix toward protection/assurance side to improve margins, though growth and customer solutions remain priorities.
  • Management expects growth in both absolute volume and APE terms to substantially improve in H2 FY26 as market adjusts to regulatory changes from master circular implemented last year.
  • CEO vision includes pan-India rollout of customer engagement and intermediary apps within 5-6 months. Data lake and analytics platform being built with fintech partners. AI/ML integration in underwriting and risk assessment is planned.

Risks flagged

  • Number of policies sold declined 14.75% YoY to 30.79 lakh, though average ticket size increased 23%. This suggests unit volume weakness that could impact long-term persistency and customer acquisition pipeline. Management attributed this to post-surrender regulation changes but expects agent productivity to improve going forward.
  • 13th month persistency declined to 75.63% from 78.23% and 49th month to 63.45% from 66.97% YoY. This decline was not voluntarily addressed by management in opening remarks, though the appointed actuary noted 13th month persistency improvement is expected to materialize in coming months. Analyst questioned this risk.
  • Management stated they are evaluating taking a stake in a standalone health insurance company but are awaiting regulatory and statutory changes. No firm timeline or commitment was provided. This delays potential diversification into adjacent health coverage markets.
  • Government has indicated 2027 timeline for reducing stake to 90%, but management acknowledged they have no direct visibility into government plans. Recent offloading announcement in some tranches is the only update. This leaves potential dilution events unpredictable for investors.

Key quotes

  • We are trying to focus... but the ultimate context is that VNB margin should improve but the volume should also... VNB margin should not come in the way for the growth of the overall business and for providing the solutions to the customer that are required for them.
  • The expense reduction is not the only goal for the corporation. It is all about expense optimization. We are open to increasing expenses also if it is required because ultimate goal is to bring about the growth in business and being able to provide services which meet the expectation of our customers.
  • Anything between 1.8 to 2 is the goal that we would like to achieve. But then we are also conscious of the situation that when the shift happens towards RBC regime these numbers would start looking quite different.
  • Dividend is not the only way to reward the investors... We have taken in fact our dividend yields are one of the better ones amongst the peer companies so there's no complaint about dividend but we have... we want again another important thing in context of LIC is whatever we deliver that should be sustainable we do not want to create hopes and then go back from there.

Research modules

Go one layer deeper.